Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8.27%23.25B | 6.16%11.2B | 21.71%43.43B | 36.62%21.47B | 49.59%10.55B | 211.01%35.68B | 140.89%15.72B | 72.05%7.05B | -41.74%11.47B | -38.80%6.52B |
| Operating income | 8.27%23.25B | 21.71%43.43B | 36.62%21.47B | 211.01%35.68B | 140.89%15.72B | -41.74%11.47B | -38.80%6.52B | |||
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Employee expense | -4.50%-4.17B | ---- | -11.27%-8.01B | -14.72%-3.99B | ---- | -25.70%-7.2B | -21.33%-3.48B | ---- | 0.62%-5.73B | 7.91%-2.87B |
| Depreciation and amortization | -1.54%-1.82B | ---- | -25.58%-3.56B | -50.57%-1.79B | ---- | -35.79%-2.84B | -14.28%-1.19B | ---- | 7.76%-2.09B | 10.30%-1.04B |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -56.61%-106.44M | -45.04%-42M |
| Special items of operating profit | 16.46%-2.66B | ---- | -7.91%-6.35B | -25.35%-3.18B | ---- | -57.50%-5.89B | -66.73%-2.54B | ---- | -0.60%-3.74B | 13.01%-1.52B |
| Operating profit | 19.70%5.42B | 28.08%9.06B | 49.97%4.53B | 316.85%7.08B | 453.93%3.02B | -386.60%-3.26B | -204.38%-853.83M | |||
| Financing cost | -64.67%-96.89M | ---- | 24.36%-138.66M | 52.13%-58.84M | ---- | ---183.32M | ---122.92M | ---- | ---- | ---- |
| Share of profits of associates | -495.83%-285K | ---- | 28.40%104K | 366.67%72K | ---- | -50.61%81K | -134.18%-27K | ---- | 665.52%164K | 707.69%79K |
| Share of profit from joint venture company | 445.19%31.65M | ---- | -49.13%43.25M | -87.20%5.81M | ---- | 194.68%85.03M | -12.34%45.36M | ---- | -123.47%-89.81M | -73.02%51.74M |
| Earning before tax | 19.65%5.36B | 28.51%8.97B | 52.12%4.48B | 308.12%6.98B | 467.13%2.94B | -320.39%-3.35B | -179.43%-802.01M | |||
| Tax | -33.49%-95.85M | ---- | -47.43%-151.77M | -52.94%-71.8M | ---- | -7.36%-102.94M | -9.21%-46.95M | ---- | -8.11%-95.89M | 13.21%-42.99M |
| After-tax profit from continuing operations | 19.42%5.26B | 28.23%8.81B | 52.11%4.41B | 299.35%6.87B | 442.90%2.9B | -340.73%-3.45B | -188.00%-844.99M | |||
| Earning after tax | 19.42%5.26B | 28.23%8.81B | 52.11%4.41B | 299.35%6.87B | 442.90%2.9B | -340.73%-3.45B | -188.00%-844.99M | |||
| Minority profit | 15.38%22.95M | ---- | 19.85%55.16M | 176.67%19.89M | ---- | 419.43%46.02M | 31.11%7.19M | ---- | -113.58%-14.41M | -58.15%5.48M |
| Profit attributable to shareholders | 19.44%5.24B | 28.29%8.76B | 51.80%4.39B | 298.85%6.83B | 439.84%2.89B | -358.91%-3.43B | -189.79%-850.47M | |||
| Basic earnings per share | 19.44%1.198 | 28.23%2.003 | 51.51%1.003 | 298.48%1.562 | 439.49%0.662 | -358.03%-0.787 | -189.86%-0.195 | |||
| Diluted earnings per share | 19.14%1.195 | 28.17%2.002 | 51.74%1.003 | 298.48%1.562 | 438.97%0.661 | -358.88%-0.787 | -189.86%-0.195 | |||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | PwC Accounting Firm | -- | -- | PricewaterhouseCoopers | -- | -- | PwC Accounting Firm | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.